Cell Impact AB (publ)
F:ICLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cell Impact AB (publ)
F:ICLA
|
SE |
|
Uniprof Real Estate Holding AG
F:UPR
|
DE |
|
E
|
Evolution Blockchain Group Inc
OTC:EVBC
|
US |
|
A
|
Arlen SA
WSE:ARL
|
PL |
|
Fast Food Indonesia Tbk PT
IDX:FAST
|
ID |
|
S
|
Satellos Bioscience Inc
F:0ITA
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ICLA's stock price target?
Not Available
ICLA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Cell Impact AB (publ)?
Projected CAGR
308%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 2 years is 308%.